Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells

被引:7
|
作者
Page, G [1 ]
Chalon, S
Emond, P
Maloteaux, JM
Hermans, E
机构
[1] Catholic Univ Louvain, Lab Pharmacol expt, FARL, B-1200 Brussels, Belgium
[2] Fac Med & Pharm, UPRESEA 1223, GEMCI, F-86005 Poitiers, France
[3] INSERM, Lab Biophys Med & Pharmaceut, F-38200 Tours, France
关键词
neuronal dopamine transporter; DA uptake; PE2I; GBR; 12935; COS cells; selective inhibitor;
D O I
10.1016/S0197-0186(01)00086-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of (E)-N-(3-iodoprop-2-enyl)-2beta-Carbomethoxy-3beta-(4'-methylphenyl) nortropane (PE2I) with the rat neuronal dopamine transporter (DAT) was studied in transfected COS cells by measuring its ability to inhibit DA uptake and by measuring its affinity in radioligand binding experiments. Saturable [H-3]DA uptake was measured in COS cells transiently transfected with the cDNA sequence encoding the rat DAT. Pharmacological characterisation of this uptake revealed functional properties with a V-max,a value of 45.05 +/- 2.62 pmol/mg protein per min and a K-m value of 2.86 +/- 0.28 muM. The specific [H-3]DA uptake was fully inhibited by 1 muM PE2I. Concentration response curves revealed the high potency of PE2I in inhibiting DA uptake (pEC(50) value of 8.70 +/- 0.33), 25 times higher than that observed for the reference DAT inhibitor, GBR 12935. On crude homogenates from transfected COS cells, PE2I displaced the specific binding of [3 H]GBR 12935 with a PKi value of 7.73 +/- 0.13. Accordingly, [I-125]PE2I was found to specifically recognise a single binding site population which is almost completely displaced by GBR 12935 and nomifensine. Saturation experiments revealed the high affinity of [I-125]PE2I (K-D value of 3.8 +/- 0.63 nM) that correlates with the high potency of PEN in inhibiting the [H-3]DA uptake. This contrasts with the results obtained with GBR 12935 for which a discrepancy was found between its high affinity in binding assays (KD value of 0.43 +/- 0.04 nM) and its rather low potency in functional assays (pEC50 value of 7.30 +/- 0.05). A relatively high level of [H-3]GBR 12935 binding was detected in non transfected COS cells. Such nomifensine resistant binding is attributed to the interaction of GBR 12935 with cytochrome P-450 as it was displaced by cis-(Z)-flupentixol (an inhibitor of cytochrome P-450). Such interaction was not observed using PE2I. Taken together, these data demonstrate that PE2I was a highly potent inhibitor of cloned DAT compared with GBR 12935 and provided a useful tool for further investigations in cells transfected with cDNA encoding the DAT. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 46 条
  • [1] Exploration of the dopamine transporter:: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I)
    Guilloteau, D
    Emond, P
    Baulieu, JL
    Garreau, L
    Frangin, Y
    Pourcelot, L
    Mauclaire, L
    Besnard, JC
    Chalon, S
    NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (04) : 331 - 337
  • [2] Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2β-carboxymethoxy-3β-(4′-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter
    Chalon, S
    Garreau, L
    Emond, P
    Zimmer, L
    Vilar, MP
    Besnard, JC
    Guilloteau, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 648 - 654
  • [3] Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments
    Stepanov, Vladimir
    Schou, Magnus
    Jarv, Jaak
    Halldin, Christer
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 293 - 300
  • [4] Synthesis of iodinated and radioiodinated (E)-N-(3-iodoprop-2-enyl)-2 beta-carbomethoxy-3 beta-(3',4'-dichlorophenyl) nortropane (beta-CDIT): A ligand for the dopamine transporter.
    Emond, P
    Boazi, M
    Duchene, A
    Chalon, S
    Besnard, JC
    Guilloteau, D
    Frangin, Y
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1997, 39 (09): : 757 - 772
  • [5] Quantitative Analysis of 18F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease
    Fazio, Patrik
    Svenningsson, Per
    Forsberg, Anton
    Jonsson, Erik G.
    Amini, Nahid
    Nakao, Ryuji
    Nag, Sangram
    Halldin, Christer
    Farde, Lars
    Varrone, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) : 714 - 720
  • [6] Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter
    Chalon, S
    Hall, H
    Saba, W
    Garreau, L
    Dollé, F
    Halldin, C
    Emond, P
    Bottlaender, M
    Deloye, JB
    Helfenbein, J
    Madelmont, JC
    Bodard, S
    Mincheva, Z
    Besnard, JC
    Guilloteau, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01): : 147 - 152
  • [7] Synthesis of (E)-N-(3-bromoprop-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl) nortropane (PE2Br) and radiolabelling of [76Br]PE2Br:: A potential ligand for exploration of the dopamine transporter by PET.
    Helfenbein, J
    Emond, P
    Loc'h, C
    Bottlaender, M
    Ottaviani, M
    Guilloteau, D
    Mazière, B
    Frangin, Y
    Chalon, S
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1999, 42 (06): : 581 - 588
  • [8] N-(3-iodoprop-2E-enyl)-2 beta-carbomethoxy-3 beta-(4'-methyl phenyl) nortropane as a selective marker for the dopamine transporter: Validation in a rat model of Parkinson's disease.
    Chalon, S
    Emond, P
    Thiercelin, C
    Bodard, S
    Garreau, L
    Frangin, Y
    Mauclaire, L
    Besnard, JC
    Guilloteau, D
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 279 - 279
  • [9] Synthesis and ligand binding of nortropane derivatives: N-substituted 2 beta-carbomethoxy-3 beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2 beta-carbomethoxy-3 beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter
    Emond, P
    Garreau, L
    Chalon, S
    Boazi, M
    Caillet, M
    Bricard, J
    Frangin, Y
    Mauclaire, L
    Besnard, JC
    Guilloteau, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1366 - 1372
  • [10] Radiosynthesis of [123I]N-(3-iodoprop-(2E)-enyl)-2α-(imino-methyl)-3β-(3′,4′-dichlorophenyl) nortropane as a potential SPET tracer for dopamine transporter
    Yu, MX
    Airaksinen, AJ
    Gee, AD
    Lötjönen, S
    Kuikka, JT
    Vepsäläinen, JJ
    Hiltunen, J
    Bergström, KA
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (12): : 1011 - 1017